Elan Corp PLC (ELN.I)
4.55EUR
4:03am EST
€0.03 (+0.66%)
€4.52
€4.55
€4.56
€4.55
9,360
397,181
€7.00
€3.15
ELN.I
About
Overall
| Beta: | 0.86 |
| Market Cap (Mil.): | €2,647.85 |
| Shares Outstanding (Mil.): | 583.74 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| ELN.I | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 3.56 | 4.64 |
| EPS (TTM): | 92.57 | -- | -- |
| ROI: | -3.03 | 1.78 | 2.79 |
| ROE: | -- | 2.39 | 3.51 |
UPDATE 1-J&J to pay $785 million for sinus-surgery company
* Cash deal includes other ear, nose, throat technology
UPDATE 4-Elan, Transition drop top drug doses after deaths
* Nine deaths in patients on top doses of Alzheimer's drug
WRAPUP 1-Addex drug flop deals blow to European biotech
* Elan, Transition hit by Alzheimer's drug setback (Adds analyst and company comment, industry detail)
RPT-UPDATE 2-Elan, Transition drop top drug doses after deaths
* Nine deaths in patients on top doses of Alzheimer's drug
UPDATE 2-HealthCor slams Biogen CEO for outsize pay package
* Calls on company to initiate sustained buyback program
Elan, Biogen change Tysabri label due to PML risk
DUBLIN, Nov 7 (Reuters) - Ireland's Elan and U.S. drugmaker Biogen Idec have amended the label of their multiple sclerosis drug Tysabri to reflect the increased risk of contracting a potentially deadly brain infection, Elan said in a statement on Saturday.
J&J slashing workforce
NEW YORK (Reuters) - Johnson & Johnson plans to cut up to 7 percent of its workforce in order to generate cost savings needed to finance increasingly costly drug research and to weather future challenges, the diversified healthcare company said on Tuesday.
J&J to slash 7,000 to 8,000 jobs
NEW YORK (Reuters) - Johnson & Johnson plans to cut up to 7 percent of its workforce in order to generate cost savings needed to finance increasingly costly drug research and to weather future challenges, the diversified healthcare company said on Tuesday.
UPDATE 4-J&J slashing workforce, cites cost of drug research
* Shares down 0.7 pct (Adds details on earlier job cuts, recent drug deals)
Europe stocks post first monthly drop since June
LONDON, Oct 30 (Reuters) - European shares fell sharply on Friday on mixed U.S. data and as traders booked profits while a key index reversed its monthly rising trend for the first time since June.
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
